{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:56:51Z","timestamp":1777589811800,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":1450,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.bbadis.2010.08.005","type":"journal-article","created":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T09:15:20Z","timestamp":1281777320000},"page":"1188-1192","source":"Crossref","is-referenced-by-count":39,"title":["Aldosterone: A cardiovascular risk factor?"],"prefix":"10.1016","volume":"1802","author":[{"given":"John W.","family":"Funder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2010.08.005_bb0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02155834","article-title":"Isolierung cines neuen krystallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den Mineralstoffwechsel","volume":"9","author":"Simpson","year":"1953","journal-title":"Experientia"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF02158515","article-title":"Konstitution des Aldosterons, des neuen Mineralocorticoids","volume":"10","author":"Simpson","year":"1953","journal-title":"Experientia"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0015","first-page":"3","article-title":"Presidential Address, Part I, Painting background: Part II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0020","first-page":"661","article-title":"Primary aldosteronism","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1210\/endo-50-2-150","article-title":"A quantitative method for the bioassay of the effect of adrenal cortical hormones on mineral metabolism","volume":"50","author":"Simpson","year":"1952","journal-title":"Endocrinol."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.25.2.170","article-title":"Production of aldosterone in isolated rat blood vessels","volume":"25","author":"Takeda","year":"1995","journal-title":"Hypertens."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0035","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1210\/endo.141.5.7529","article-title":"Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy","volume":"141","author":"Takeda","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0040","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1210\/endo.138.8.5326","article-title":"Aldosterone biosynthesis in the rat brain","volume":"138","author":"Gomez-Sanchez","year":"1997","journal-title":"Endocrinol."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.med.0000162079.18463.7f","article-title":"Cardiac synthesis of aldosterone","volume":"12","author":"Funder","year":"2005","journal-title":"Curr. Opin. Endocrinol. Diab."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0050","doi-asserted-by":"crossref","first-page":"R992","DOI":"10.1152\/ajpregu.00071.2009","article-title":"Trilostane, FAD 286 and the role of aldosterone in the central regulation of blood pressure","volume":"296","author":"Funder","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0055","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1210\/en.2004-0295","article-title":"Origin of aldosterone in the rat heart","volume":"145","author":"Gomez-Sanchez","year":"2004","journal-title":"Endocrinol."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/endo-85-2-381","article-title":"Effect of plasma (K+) on the secretion of aldosterone","volume":"85","author":"Funder","year":"1969","journal-title":"Endocrinol."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0065","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1172\/JCI119249","article-title":"Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion","volume":"99","author":"Okubo","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0070","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0075","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.80.19.6056","article-title":"Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity","volume":"80","author":"Krozowski","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0080","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1440-1681.1987.tb02422.x","article-title":"High affinity aldosterone binding sites (Type 1 receptors) in rat heart","volume":"14","author":"Pearce","year":"1987","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0085","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0090","first-page":"E601","article-title":"Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies","volume":"270","author":"Myles","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target-tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0100","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1210\/endo.137.12.8940344","article-title":"Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies","volume":"137","author":"Funder","year":"1996","journal-title":"Endocrinol."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0105","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.1633591100","article-title":"Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor","volume":"100","author":"Fjeld","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/hc3001.091458","article-title":"Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries","volume":"104","author":"Ward","year":"2001","journal-title":"Circ."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0115","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"(2009) Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction","volume":"54","author":"Mihailidou","year":"2009","journal-title":"Hypertens."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0120","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis and treatment of patients with primary aldosteronism","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0125","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0009-9260(71)80050-8","article-title":"Retroperitoneal pneumography in the investigation of adrenal disease","volume":"22","author":"McLachlan","year":"1971","journal-title":"Clin Radiol"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0135","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/HYPERTENSIONAHA.107.109439","article-title":"Aldosterone and metabolic syndrome is increased aldosterone in metabolic syndrome patients an additional risk factor?","volume":"51","author":"Krug","year":"2008","journal-title":"Hypertens."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.HYP.0000231338.41548.fc","article-title":"Plasma aldosterone is independently associated with the metabolic syndrome","volume":"48","author":"Bochud","year":"2006","journal-title":"Hypertens."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0145","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.HYP.0000253258.36141.c7","article-title":"Association of adrenal steroids with hypertension and the metabolic syndrome in blacks","volume":"49","author":"Kidambi","year":"2007","journal-title":"Hypertens."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0150","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/dc07-0525","article-title":"Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients","volume":"30","author":"Colussi","year":"2007","journal-title":"Diab Care"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0155","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCULATIONAHA.107.708537","article-title":"Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors\u2014the Framingham offspring study","volume":"116","author":"Ingelsson","year":"2007","journal-title":"Circ."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0160","first-page":"1","article-title":"Endres for the Participants of the German Conn's Registry. Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry","volume":"42","author":"Reincke","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0165","doi-asserted-by":"crossref","first-page":"603","DOI":"10.33549\/physiolres.930123","article-title":"Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus?","volume":"50","author":"Widimsky","year":"2001","journal-title":"Physiol Res"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0170","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0175","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism, a controlled cross-sectional study","volume":"53","author":"Matrazova","year":"2009","journal-title":"Hypertens."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tem.2005.02.003","article-title":"The renin-angiotensin-aldosterone system, glucose metabolism and diabetes","volume":"16","author":"Giacchetti","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0185","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1097\/HJH.0b013e328332d1d5","article-title":"Depressive illness, the sympathetic nervous system and cardiac risk","volume":"27","author":"Esler","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0190","first-page":"358","article-title":"Hyperaldosteronism (Conn's disease) presenting as depression","volume":"40","author":"Malinow","year":"1979","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0195","first-page":"537","article-title":"Primary Hyperaldosteronism and depression","volume":"97","author":"Avery","year":"1984","journal-title":"N.Z. Mea. J."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0200","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1176\/appi.ajp.162.6.1226","article-title":"Conn's syndrome presenting as depression","volume":"162","author":"Khurshid","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0205","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000093956","article-title":"Psychological aspects of primary aldosteronism","volume":"75","author":"Sonino","year":"2006","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-244X-3-15","article-title":"The rennin-angiotensin-aldosterone system in patients with depression compared to controls\u2014a sleep study","volume":"3","author":"Murck","year":"2003","journal-title":"BMC Psych."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0215","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.arcmed.2005.03.046","article-title":"Increased plasma aldosterone in patients with clinical depression","volume":"36","author":"Emanuele","year":"2005","journal-title":"Arch Med Res"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0220","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J. Clin. Endocrinol."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0225","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2003-032149","article-title":"Distinguishing the antihypertensive and electrolyte effects of eplerenone","volume":"89","author":"Levy","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0230","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0235","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0240","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure","volume":"115","author":"Guder","year":"2007","journal-title":"Circ."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0245","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1161\/CIRCHEARTFAILURE.109.868513","article-title":"Serum cortisol as a useful predictor of cardiac events in patients with heart failure\u2014the impact of oxidative stress","volume":"2","author":"Yamaji","year":"2009","journal-title":"Circ. Heart Failure"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0250","first-page":"E657","article-title":"Determinants of cardiac fibrosis in experimental hypermineralocorticoid states","volume":"269","author":"Young","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bbadis.2010.08.005_bb0255","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/HYPERTENSIONAHA.109.146936","article-title":"Aldosterone, sodium and hypertension, lessons from torcetrapib?","volume":"55","author":"Funder","year":"2010","journal-title":"Hypertens."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2061","article-title":"Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6","volume":"16","author":"Doi","year":"2010","journal-title":"Nature Med."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0265","doi-asserted-by":"crossref","first-page":"15845","DOI":"10.1073\/pnas.0507358102","article-title":"The highly conserved cardiac glycoside binding site of Na.K-ATPase plays a role in blood pressure regulation","volume":"102","author":"Dostanic-Larson","year":"2005","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0270","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/01.HYP.29.1.401","article-title":"Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors","volume":"29","author":"Laredo","year":"1997","journal-title":"Hypertens."},{"key":"10.1016\/j.bbadis.2010.08.005_bb0275","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00004872-199602000-00002","article-title":"Endogenous ouabain, sodium balance and blood pressure: a review and an hypothesis","volume":"14","author":"Hamlyn","year":"1996","journal-title":"J Hypertens"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443910001675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443910001675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T13:33:34Z","timestamp":1740404014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443910001675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0925443910001675"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2010.08.005","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}